Global Prostate Cancer Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Prostate Cancer Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Market Overview:

The latest research study on the global Prostate Cancer Devices market finds that the global Prostate Cancer Devices market reached a value of USD 645.56 million in 2022. It’s expected that the market will achieve USD 892.98 million by 2028, exhibiting a CAGR of 5.56% during the forecast period.

Segmentation Overview:

By type, Cryotherapy Devices segment accounted for the largest share of market in 2022.

High Intensity Focused Ultrasound (HIFU) Devices

High intensity focused ultrasound (HIFU) is a non-invasive treatment technique, which uses non-ionizing ultrasound to heat tissues. High intensity focused ultrasound (HIFU) devices is a non-invasive medical device, which uses high intensity focused ultrasound to treat prostate cancer and benign prostatic hyperplasia (BPH).

Cryotherapy Devices

Cryotherapy Devices use very cold temperatures to freeze and kill prostate cancer cells and most prostates. Doctors use transrectal ultrasound (TRUS) to guide multiple hollow probes (needles) through the skin between the anus and scrotum and into the prostate. Then, the extremely cold gas freezes through the needle and destroys the prostate.

Key Companies in the global Prostate Cancer Devices market covered in Chapter 3:

Elekta
Galil Medical
Profound Medical
Eckert & Ziegler BEBIG
Siemens Healthcare
Theragenics
Intuitive Surgical
SonaCare Medical
Varian Medical Systems
EDAP TMS
IsoRay
C. R. Bard
Philips Healthcare

In Chapter 4 and Chapter 14.2, on the basis of types, the Prostate Cancer Devices market from 2018 to 2029 is primarily split into:

High Intensity Focused Ultrasound (HIFU) Devices
Cryotherapy Devices

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Prostate Cancer Devices market from 2018 to 2029 covers:

Hospital
Clinic
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)